CLINICAL_TRIALS
trial_result
· 2015-03-11
Clinical Trial Update: Phase II Study of Vandetanib in Individuals With Kidney Cancer [Phase 2]
Summary
Phase II study of vandetanib in renal cancer and Von Hippel-Lindau syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Renal Cancer, Von Hippel Lindau | Phase 2 | Status: COMPLETED | Results posted: 2015-03-11